|
Spectrum of activity of levonadifloxacin | Organisms |
|
Excellent Gram-positive bacteria coverage | (i) Staphylococcus aureus: MSSA, MRSA, QRSA, VRSA |
(ii) Coagulase-negative staphylococci |
(iii) Staphylococcus epidermidis |
(iv) Streptococcus pneumoniae |
(v) Streptococcus pyogenes |
(vi) Streptococcus agalactiae |
(vii) Viridans group streptococci |
|
Quinolone sensitive Gram-negative (at par with ciprofloxacin) | (i) Escherichia coli |
(ii) Klebsiella spp. |
(iii) Enterobacter spp. |
(iv) Citrobacter spp. |
(v) Proteus spp. |
vi) Providencia spp. |
(vii) Pseudomonas aeruginosa |
(viii) Moraxella catarrhalis |
(ix) Haemophilus influenzae |
|
Good anaerobic coverage | (i) Clostridium difficile |
(ii) Clostridium perfringens |
(iii) Cutibacterium (Propionibacterium) acnes |
(iv) Peptostreptococcus spp. |
|
Good atypical bacteria coverage | (i) Mycoplasma |
(ii) Chlamydia pneumoniae |
(iii) Chlamydia trachomatis |
(iv) Legionella pneumophila |
(v) Ureaplasma |
|